+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Medical Affairs Outsourcing Market by End User, Delivery Mode, Outsourcing Model, Therapeutic Area, Service Type - Global Forecast to 2030- Product Image
Medical Affairs Outsourcing Market by End User, Delivery Mode, Outsourcing Model, Therapeutic Area, Service Type - Global Forecast to 2030- Product Image
Sale

Medical Affairs Outsourcing Market by End User, Delivery Mode, Outsourcing Model, Therapeutic Area, Service Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4896732
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The medical affairs outsourcing market is evolving rapidly as life sciences organizations seek specialized expertise, regulatory agility, and cost-efficient solutions. Senior leaders now require data-driven insights to navigate increasing complexity, advance stakeholder engagement, and optimize medical affairs strategies for competitive differentiation.

Market Snapshot: Medical Affairs Outsourcing Market

The Medical Affairs Outsourcing Market grew from USD 11.16 billion in 2024 to USD 12.84 billion in 2025. It is expected to maintain a strong growth trajectory at a CAGR of 14.70%, reaching USD 25.43 billion by 2030. This expansion is fueled by heightened regulatory requirements, emerging biologics, and the intensifying need for efficient delivery of scientific and medical information within global pharmaceutical, biotech, and medical device organizations.

Scope & Segmentation

  • End User Types: Biotech Companies (large, small); Contract Research Organizations (Phase I, Phase II/III, laboratory, preclinical); Medical Device Companies (diagnostic, monitoring, therapeutic); Pharmaceutical Companies (generic, innovator)
  • Delivery Modes: Hybrid models; Offsite centers; Onsite embedded teams
  • Outsourcing Models: End-to-end solutions; Functional service providers such as medical communications, medical writing, pharmacovigilance; Hybrid configurations
  • Therapeutic Areas: Cardiovascular (arrhythmia, heart failure, hypertension); Infectious Diseases (hepatitis, HIV/AIDS, respiratory infections); Neurology (Alzheimer’s, epilepsy, Parkinson’s); Oncology (breast, hematological, lung cancers)
  • Service Types: Medical audit compliance; Medical communications (education, publications, training); Medical information; Medical strategy; Medical writing (clinical trial, manuscript, regulatory); Pharmacovigilance (case processing, risk management, signal detection)
  • Geographic Regions: Americas (United States, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (including 20 countries across Western and emerging markets); Asia-Pacific (China, India, Japan, and others)
  • Leading Companies: IQVIA Holdings Inc., Laboratory Corporation of America Holdings, Syneos Health, PPD Inc., ICON plc, Parexel International, Charles River Laboratories, Medpace Holdings, WuXi AppTec, UDG Healthcare plc

Key Takeaways

  • Digital transformation is central to medical affairs outsourcing, supporting real-time collaboration, virtual engagement, and data-driven insights across therapeutic areas.
  • Providers are expanding capabilities to deliver both cost savings and strategic alignment, ensuring that outsourced medical affairs functions accelerate development timelines and drive adoption.
  • Segmented delivery models enable organizations to tailor their partnership approach, optimizing between onsite, offsite, and hybrid resources based on portfolio complexity and regional regulation.
  • Strategic alliances between providers and tech firms are advancing the use of AI in literature surveillance, medical writing, and pharmacovigilance activities, helping clients maintain scientific excellence and compliance.
  • Regional expertise and a flexible operational footprint enable providers to respond effectively to market-specific regulatory challenges and supply chain needs.

Tariff Impact on Medical Affairs Outsourcing

Recent U.S. tariff measures have increased costs on laboratory reagents and specialized instrumentation, driving both sponsors and providers to reassess their supply chains and shift critical operations onshore. Flexible contracting strategies, blended delivery models combining domestic and offshore resources, and digital platforms managing hybrid teams are now commonplace. Building multi-tier supplier networks helps ensure supply continuity and operational resilience, directly impacting the value proposition of outsourcing in this sector.

Methodology & Data Sources

This analysis used a rigorous combination of structured interviews with industry leaders, expert workshops, and secondary research from peer-reviewed publications, regulatory filings, conference materials, and white papers. Data triangulation and consistency checks were applied to validate findings and segment relevance. Research processes preserved geographic diversity and maintained strict confidentiality throughout.

Why This Report Matters

  • Enables informed decision-making by delivering segmented, actionable insights into end user needs, regional challenges, and evolving delivery models in the medical affairs outsourcing market.
  • Provides a reliable reference for aligning provider capabilities with strategic priorities, compliance requirements, and risk management initiatives.
  • Helps senior leaders anticipate implications of regulatory shifts, digital innovation, and cost pressures on global outsourcing strategy.

Conclusion

This report delivers a robust framework for understanding the evolving landscape of medical affairs outsourcing. Its strategic insights empower senior decision-makers to optimize partnerships and maintain a strong competitive position in a dynamic environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Medical Affairs Outsourcing Market, by End User
8.1. Introduction
8.2. Biotech Companies
8.2.1. Large Biotech
8.2.2. Small Biotech
8.3. Contract Research Organizations
8.3.1. Clinical CROS
8.3.1.1. Phase I CROS
8.3.1.2. Phase II III CROS
8.3.2. Laboratory CROS
8.3.3. Preclinical CROS
8.4. Medical Device Companies
8.4.1. Diagnostic Devices
8.4.2. Monitoring Devices
8.4.3. Therapeutic Devices
8.5. Pharmaceutical Companies
8.5.1. Generic Pharma
8.5.2. Innovator Pharma
9. Medical Affairs Outsourcing Market, by Delivery Mode
9.1. Introduction
9.2. Hybrid
9.3. Offsite
9.4. Onsite
10. Medical Affairs Outsourcing Market, by Outsourcing Model
10.1. Introduction
10.2. End to End Solutions
10.3. Functional Service Provider
10.3.1. Medical Communications
10.3.2. Medical Writing
10.3.3. Pharmacovigilance
10.4. Hybrid Model
11. Medical Affairs Outsourcing Market, by Therapeutic Area
11.1. Introduction
11.2. Cardiovascular
11.2.1. Arrhythmia
11.2.2. Heart Failure
11.2.3. Hypertension
11.3. Infectious Disease
11.3.1. Hepatitis
11.3.2. HIV AIDS
11.3.3. Respiratory Infection
11.4. Neurology
11.4.1. Alzheimer Disease
11.4.2. Epilepsy
11.4.3. Parkinson Disease
11.5. Oncology
11.5.1. Breast Cancer
11.5.2. Hematological Cancer
11.5.3. Lung Cancer
12. Medical Affairs Outsourcing Market, by Service Type
12.1. Introduction
12.2. Medical Audit Compliance
12.3. Medical Communications
12.3.1. Medical Education
12.3.2. Scientific Publications
12.3.3. Training
12.4. Medical Information
12.5. Medical Strategy
12.6. Medical Writing
12.6.1. Clinical Trial Writing
12.6.2. Manuscript Writing
12.6.3. Regulatory Writing
12.7. Pharmacovigilance
12.7.1. Case Processing
12.7.2. Risk Management
12.7.3. Signal Detection
13. Americas Medical Affairs Outsourcing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Medical Affairs Outsourcing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Medical Affairs Outsourcing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. IQVIA Holdings Inc.
16.3.2. Laboratory Corporation of America Holdings
16.3.3. Syneos Health, Inc.
16.3.4. PPD, Inc.
16.3.5. ICON plc
16.3.6. Parexel International Corporation
16.3.7. Charles River Laboratories International, Inc.
16.3.8. Medpace Holdings, Inc.
16.3.9. WuXi AppTec Co., Ltd.
16.3.10. UDG Healthcare plc
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. MEDICAL AFFAIRS OUTSOURCING MARKET MULTI-CURRENCY
FIGURE 2. MEDICAL AFFAIRS OUTSOURCING MARKET MULTI-LANGUAGE
FIGURE 3. MEDICAL AFFAIRS OUTSOURCING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. MEDICAL AFFAIRS OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. MEDICAL AFFAIRS OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. MEDICAL AFFAIRS OUTSOURCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY LARGE BIOTECH, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHASE I CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHASE II III CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL CROS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY LABORATORY CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PRECLINICAL CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY GENERIC PHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INNOVATOR PHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY HYBRID, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OFFSITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONSITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END TO END SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY FUNCTIONAL SERVICE PROVIDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY FUNCTIONAL SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY HYBRID MODEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY HIV AIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY RESPIRATORY INFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ALZHEIMER DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PARKINSON DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY HEMATOLOGICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL AUDIT COMPLIANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL EDUCATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SCIENTIFIC PUBLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY TRAINING, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL INFORMATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL STRATEGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL TRIAL WRITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MANUSCRIPT WRITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY WRITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CASE PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY RISK MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SIGNAL DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL CROS, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY FUNCTIONAL SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL CROS, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY FUNCTIONAL SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 118. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 120. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 121. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL CROS, 2018-2030 (USD MILLION)
TABLE 122. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, 2018-2030 (USD MILLION)
TABLE 123. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 124. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 125. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 126. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY FUNCTIONAL SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 127. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 128. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 129. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 130. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 131. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 132. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 133. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2018-2030 (USD MILLION)
TABLE 134. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2018-2030 (USD MILLION)
TABLE 135. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 136. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 138. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 139. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL CROS, 2018-2030 (USD MILLION)
TABLE 140. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, 2018-2030 (USD MILLION)
TABLE 141. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 142. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 143. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 144. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY FUNCTIONAL SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 145. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 146. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 147. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 148. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 149. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 150. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 151. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2018-2030 (USD MILLION)
TABLE 152. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2018-2030 (USD MILLION)
TABLE 153. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL CROS, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY FUNCTIONAL SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL CROS, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 178. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 179. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 180. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY FUNCTIONAL SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 181. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 182. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 183. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 184. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 185. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 186. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 187. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2018-2030 (USD MILLION)
TABLE 188. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2018-2030 (USD MILLION)
TABLE 189. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL CROS, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY FUNCTIONAL SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2018-2030 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2018-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 212. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL CROS, 2018-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, 2018-2030 (USD MILLION)
TABLE 214. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 216. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY FUNCTIONAL SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 218. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 220. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 222. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 224. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2018-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2018-2030 (USD MILLION)
TABLE 226. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 227. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 229. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 230. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL CROS, 2018-2030 (USD MILLION)
TABLE 231. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, 2018-2030 (USD MILLION)
TABLE 232. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 233. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 234. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 235. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY FUNCTIONAL SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 236. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 237. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 238. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 239. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 240. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 241. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 242. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2018-2030 (USD MILLION)
TABLE 243. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2018-2030 (USD MILLION)
TABLE 244. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 245. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 247. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 248. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL CROS, 2018-2030 (USD MILLION)
TABLE 249. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, 2018-2030 (USD MILLION)
TABLE 250. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 251. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 252. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 253. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY FUNCTIONAL SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 254. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 255. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 256. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 257. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 258. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 259. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 260. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2018-2030 (USD MILLION)
TABLE 261. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2018-2030 (USD MILLION)
TABLE 262. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL CROS, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 271. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY FUNCTIONAL SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 272. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 273. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 274. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 275. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 276. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 277. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 278. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2018-2030 (USD MILLION)
TABLE 279. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2018-2030 (USD MILLION)
TABLE 280. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 281. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 283. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 284. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL CROS, 2018-2030 (USD MILLION)
TABLE 285. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, 2018-2030 (USD MILLION)
TABLE 286. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 287. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 288. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 289. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY FUNCTIONAL SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 290. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 291. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 292. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 293. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 294. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 295. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 296. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2018-2030 (USD MILLION)
TABLE 297. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2018-2030 (USD MILLION)
TABLE 298. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 299. SPAIN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. SPAIN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 301. SPAIN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 302. SPAIN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL CROS, 2018-2030 (USD MILLION)
T

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Medical Affairs Outsourcing market report include:
  • IQVIA Holdings Inc.
  • Laboratory Corporation of America Holdings
  • Syneos Health, Inc.
  • PPD, Inc.
  • ICON plc
  • Parexel International Corporation
  • Charles River Laboratories International, Inc.
  • Medpace Holdings, Inc.
  • WuXi AppTec Co., Ltd.
  • UDG Healthcare plc

Table Information

Report AttributeDetails
No. of Pages186
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 12.84 Billion
Forecasted Market Value ( USD ) by 2030 $ 25.43 Billion
Compound Annual Growth Rate14.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Medical Affairs Outsourcing Market Report 2025 - Product Image

Medical Affairs Outsourcing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Pharmacovigilance Market Size, Share & Trends Analysis Report by Product Life Cycle, Service Provider (In-house, Contract Outsourcing), Type, Therapeutic Area, Process Flow, End Use, Region, and Segment Forecasts, 2024-2030 - Product Image

Pharmacovigilance Market Size, Share & Trends Analysis Report by Product Life Cycle, Service Provider (In-house, Contract Outsourcing), Type, Therapeutic Area, Process Flow, End Use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 295 Pages
  • Global
From
Europe Medical Affairs Outsourcing Market Size, Share & Trends Analysis Report By Services (Medical Writing & Publishing, Medical Monitoring), By Industry, By Medical Devices Type, By Country, And Segment Forecasts, 2025 - 2030 - Product Image

Europe Medical Affairs Outsourcing Market Size, Share & Trends Analysis Report By Services (Medical Writing & Publishing, Medical Monitoring), By Industry, By Medical Devices Type, By Country, And Segment Forecasts, 2025 - 2030

  • Report
  • 80 Pages
  • Europe
From
Cancer Immunotherapy Drug Discovery Outsourcing Market by Service Type, Therapeutic Modality, Workflow Stage, End User - Global Forecast to 2030 - Product Image

Cancer Immunotherapy Drug Discovery Outsourcing Market by Service Type, Therapeutic Modality, Workflow Stage, End User - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Contract Research Outsourcing - Global Strategic Business Report - Product Image

Contract Research Outsourcing - Global Strategic Business Report

  • Report
  • 453 Pages
  • Global
From

About the Medical Affairs Outsourcing Market

Medical Affairs Outsourcing is a growing segment of the healthcare services industry. It involves the outsourcing of medical affairs activities such as clinical trial management, medical writing, regulatory affairs, and pharmacovigilance. This allows pharmaceutical and biotechnology companies to focus on their core competencies while leveraging the expertise of specialized service providers. Medical Affairs Outsourcing is a cost-effective way to access the latest technology and expertise, while also providing access to a global network of medical professionals. It also helps to reduce the time and cost associated with the development of new drugs and medical devices. Companies in the Medical Affairs Outsourcing market include Parexel, ICON, Syneos Health, PRA Health Sciences, and QuintilesIMS. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.